Drug Profile
Erythromycin salnacedin
Alternative Names: Actagen; G 101Latest Information Update: 09 Mar 2015
Price :
$50
*
At a glance
- Originator Genta
- Class Antiacnes; Antibacterials; Expectorants; Macrolides; Salicylates
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acne
Most Recent Events
- 28 Aug 2001 Discontinued-III for Acne in France (Topical)
- 28 Aug 2001 Discontinued-III for Acne in USA (Topical)
- 21 Sep 1999 No-Development-Reported for Acne in France (Topical)